Goodwin advised Mariana Oncology on the fundraising. Mariana Oncology Inc. announced its oversubscribed $175 million Series B financing co-led by Deep Track Capital and Forbion, and...
You must be a Standard 1 Year member to access this content.
Goodwin advised Nuvig Therapeutics on the deal. Nuvig Therapeutics announced its $47 million Series A financing and the launch of the company to develop novel therapeutics that...
You must be a Standard 1 Year member to access this content.
Goodwin advised Blackstone Life Sciences on the deal. Blackstone Life Sciences announced its strategic, risk-sharing financing collaboration with Sanofi, in which Blackstone will provide Sanofi with up...
You must be a Standard 1 Year member to access this content.
Latham & Watkins represented OpenSea, while Goodwin represented Dharma Labs in the transaction. OpenSea, an nonfungible token (NFT) marketplace, has announced that it is acquiring Dharma Labs....
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised AbCellera on the deal. AbCellera (Nasdaq: ABCL) announced its acquisition of TetraGenetics. AbCellera is a technology company with a centralized operating system for next-generation...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Omega Funds on the deal. Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company exploiting a broad DDR-based platform and small...
You must be a Standard 1 Year member to access this content.
